Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Francesco Blasi, Stefano Aliberti & Paolo Tarsia. (2007) Clinical applications of azithromycin microspheres in respiratory tract infections. International Journal of Nanomedicine 2:4, pages 551-559.
Read now
Read now
Silvano Esposito & Marco Fiore. (2007) Community-acquired pneumonia: is it time to shorten the antibiotic treatment?. Expert Review of Anti-infective Therapy 5:6, pages 933-938.
Read now
Read now
Lala M. Dunbar, Mohammed M. Khashab, James B. Kahn, Neringa Zadeikis, Jim X. Xiang & Alan M. Tennenberg. (2004) Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens. Current Medical Research and Opinion 20:4, pages 555-563.
Read now
Read now
N. Sopena, C. Martínez-Vázquez, J.R. Rodríguez-Suárez, F. Segura, A. Valencia & M. Sabrià. (2004) Comparative Study of the Efficacy and Tolerance of Azithromycin versus Clarithromycin in the Treatment of Community- Acquired Pneumonia in Adults. Journal of Chemotherapy 16:1, pages 102-103.
Read now
Read now
G. Samonis, S. Maraki, N. Anatoliotakis, M. Anatoliotaki, H. Apostolakou, A. N. Margioris, Y. Tselentis & D. P. Kontoyiannis. (2002) Effects of erythromycin, clarithromycin, roxithromycin and azithromycin on murine gut colonization by Candida albicans. Medical Mycology 40:2, pages 139-142.
Read now
Read now
Articles from other publishers (23)
Thakul Rattanasuwan, Alex Ebied & Adonice Khoury. (2021) Short-Course Azithromycin for Lower Respiratory Tract Infection in Adults. Infectious Diseases in Clinical Practice 29:3, pages e140-e145.
Crossref
Crossref
Anton Firth & Praveen Prathapan. (2020) Azithromycin: The First Broad-spectrum Therapeutic. European Journal of Medicinal Chemistry 207, pages 112739.
Crossref
Crossref
Donna Kruger & Praveen Prathapan. (2020) Azithromycin: The First Broad-spectrum Therapeutic. Journal of Translational Autoimmunity, pages 100062.
Crossref
Crossref
Suraj Panthi, Amy R. Sapkota, Greg Raspanti, Sarah M. Allard, Anthony Bui, Hillary A. Craddock, Rianna Murray, Libin Zhu, Cheryl East, Eric Handy, Mary Theresa Callahan, Joseph Haymaker, Prachi Kulkarni, Brienna Anderson, Shani Craighead, Samantha Gartley, Adam Vanore, Walter Q. Betancourt, Rico Duncan, Derek Foust, Manan Sharma, Shirley A. Micallef, Charles Gerba, Salina Parveen, Fawzy Hashem, Eric May, Kalmia Kniel, Mihai Pop, Sadhana Ravishankar & Amir Sapkota. (2019) Pharmaceuticals, herbicides, and disinfectants in agricultural water sources. Environmental Research 174, pages 1-8.
Crossref
Crossref
A. I. Sinopalnikov. (2018) Short antibiotic courses in community-acquired pneumonia in adults: less is better. Medical Council:15, pages 124-130.
Crossref
Crossref
Jesús López-Alcalde, Ricardo Rodriguez-Barrientos, Jesús Redondo-Sánchez, Javier Muñoz-Gutiérrez, José María Molero García, Carmen Rodríguez-Fernández, Julio Heras-Mosteiro, Jaime Marin-Cañada, Jose Casanova-Colominas, Amaya Azcoaga-Lorenzo, Virginia Hernandez Santiago & Manuel Gómez-García. (2018) Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients. Cochrane Database of Systematic Reviews 2018:9.
Crossref
Crossref
Stefano Aliberti, Fabio Giuliani, Julio Ramirez & Francesco Blasi. (2015) How to choose the duration of antibiotic therapy in patients with pneumonia. Current Opinion in Infectious Diseases 28:2, pages 177-184.
Crossref
Crossref
Robert S. Holzman & Michael S. Simberkoff. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
2183
2189.e3
.
Sumathi Sivapalasingam & Neal H. Steigbigel. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
358
376.e6
.
György Losonczy. (2012) Early and late mortality of patients with community acquired pneumonia. Orvosi Hetilap 153:23, pages 884-890.
Crossref
Crossref
Ricardo Rodriguez-Barrientos, Jesús López-Alcalde, Carmen Rodríguez-Fernández, Javier Muñoz-Gutiérrez, Manuel Gómez-García, José María Molero-García, Jose Casanova-Colominas, Jaime Marin-Cañada, Jesús Redondo-Sánchez & María Luz Vila-Méndez. (2011) Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Grant W. Waterer, Jordi Rello & Richard G. Wunderink. (2011) Management of Community-acquired Pneumonia in Adults. American Journal of Respiratory and Critical Care Medicine 183:2, pages 157-164.
Crossref
Crossref
SUMATHI SIVAPALASINGAM & NEAL H. STEIGBIGEL. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
427
448
.
Jonathan Z. Li, Lisa G. Winston, Dan H. Moore & Stephen Bent. (2007) Efficacy of Short-Course Antibiotic Regimens for Community-Acquired Pneumonia: A Meta-analysis. The American Journal of Medicine 120:9, pages 783-790.
Crossref
Crossref
Nikole M Scalera & Thomas M File. (2007) How long should we treat community-acquired pneumonia?. Current Opinion in Infectious Diseases 20:2, pages 177-181.
Crossref
Crossref
Andrew F. Shorr, Mohammed M. Khashab, Jim X. Xiang, Alan M. Tennenberg & James B. Kahn. (2006) Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients. Respiratory Medicine 100:12, pages 2129-2136.
Crossref
Crossref
Gregory Moran. (2006) Approaches to treatment of community-acquired pneumonia in the Emergency Department and the appropriate role of fluoroquinolones. The Journal of Emergency Medicine 30:4, pages 377-387.
Crossref
Crossref
C. Mayaud, A. Souidi, M. Fartoukh & A. Parrot. (2005) Jusqu’où faut-il réduire la durée de l’antibiothérapie au cours des infections respiratoires basses communautaires ?. Revue de Pneumologie Clinique 61:2, pages 61-66.
Crossref
Crossref
Michael S. Niederman. (2005) Principles of appropriate antibiotic use. International Journal of Antimicrobial Agents 26, pages S170-S175.
Crossref
Crossref
Thomas M. FileJr.Jr.. (2004) Clinical Efficacy of Newer Agents in Short-Duration Therapy for Community-Acquired Pneumonia. Clinical Infectious Diseases 39:Supplement_3, pages S159-S164.
Crossref
Crossref
Thomas M. FileJr.Jr.. (2003) A new dosing paradigm: High-dose, short-course fluoroquinolone therapy for community-acquired pneumonia. Clinical Cornerstone 5, pages S21-S28.
Crossref
Crossref
George G. Zhanel, Maria Dueck, Daryl J. Hoban, Lavern M. Vercaigne, John M. Embil, Alfred S. Gin & James A. Karlowsky. (2001) Review of Macrolides and Ketolides. Drugs 61:4, pages 443-498.
Crossref
Crossref
S. Schönwald, I. Kuzman, K. Orešković, V. Burek, V. Škerk, V. Car, D. Božinović, J. Čulig & S. Radošević. (1999) Azithromycin: Single 1.5g dose in the treatment of patients with atypical pneumonia syndrome—A randomized study. Infection 27:3, pages 198-202.
Crossref
Crossref